A Single Center Analysis of Advanced Non-small Cell Lung Cancer Patients Treated with Immunotherapy in Real-world Practice
Background and objective In recent years, a number of clinical trials have shown that immunocheckpoint inhibitors (ICI) have brought survival benefits to patients with advanced non-small cell lung cancer (NSCLC), however, such clinical trials comprise cohorts selected based on strict and complex ent...
Main Authors: | Yanxia LIU, Tongmei ZHANG, Yuan GAO, Yang QU, Baohua LU, Hongmei ZHANG, Qunhui WANG, Jie LI, Fanbin HU, Baolan LI |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-11-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.11.02 |
Similar Items
-
Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer
by: Jun NI, et al.
Published: (2021-03-01) -
Application of Bevacizumab in Non-small Cell Lung Cancer
by: Ping XU, et al.
Published: (2017-04-01) -
Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
by: Hye Jung Park, et al.
Published: (2021-06-01) -
Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01) -
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents
by: Mariona Riudavets, et al.
Published: (2020-09-01)